Here is how Ardelyx (ARDX) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Ardelyx (ARDX) This Year?
Related Posts
Berkshire Bought New Stocks, Shed Some Big Names in First Quarter Without Buffett as CEO
Berkshire Hathaway is shaking up its portfolio after getting a new CEO.
From High-Yield to High-Growth: 3 Stocks Boosting Dividends
Three big-name stocks recently added more juice to their dividends.
Volatility to Turn Higher as Inflation Resurfaces: Stocks to Watch
Inflation is the biggest risk in this environment amid the Strait of Hormuz blockade, which continues to pressure global energy prices.